Immunotherapy injection in tonsils for dust mite allergies
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This study tests a new way to treat allergic rhinitis (hay fever) caused by dust mites. Instead of allergy shots under the skin or drops under the tongue, the treatment is given as an injection into the tonsils. It aims to reduce allergy symptoms like sneezing and a runny nose.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 5 and 60 years old.
- You have allergic rhinitis caused by dust mites, confirmed by a positive allergy test.
- You have symptoms like sneezing, runny nose, nasal itching, or stuffy nose for at least 1 hour a day.
- You are willing to follow the study procedures and sign a consent form (or have a guardian sign if you are under 18).
- You have not had allergy immunotherapy (shots or drops) in the past year, and you are not taking beta-blockers.
- You are not pregnant or breastfeeding, and you agree not to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to treat allergies by injecting allergy medicine directly into the tonsils. It may help people with hay fever who haven't gotten relief from standard treatments or want to avoid long-term medication.
This trial tests a new allergy shot that may reduce symptoms of dust mite allergies, like sneezing, runny nose, and itchy eyes. It might also help with mild asthma caused by dust mites.
This study tests an investigational injection (GR1802) that may help reduce seasonal allergy symptoms when standard allergy medications aren't enough. If you qualify, you'll receive the injection during the pollen season to see if it improves your sneezing, runny nose, and itchy eyes.
This trial tests whether a procedure that shrinks the tissue inside your nose (called radiofrequency ablation) plus allergy shots (immunotherapy) helps reduce severe nasal blockage caused by dust mite allergy. It aims to improve breathing and reduce allergy symptoms.
This trial tests an under-the-tongue tablet for people with dust mite allergies causing moderate to severe nasal symptoms or mild-to-moderate asthma. The goal is to see if it improves symptoms and can replace or reduce the need for allergy medicines.
This Phase 3 study tests whether dust-mite allergy treatment (likely allergy shots) can reduce allergy symptoms and improve safety. It focuses on people whose nose/eye allergy is triggered by house dust mites and who may also have controlled asthma.
Hear when a new Allergic Rhinitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.